Cerevel, Cyclica partner on AI-based drug discovery

By The Science Advisory Board staff writers

July 27, 2020 -- Cerevel Therapeutics and Cyclica have announced a research collaboration that will use artificial intelligence (AI) to develop new neurological medicines.

The companies will develop an AI-augmented, integrated technology platform, that will enable multiobjective, polypharmacology-informed drug design. Cerevel will use Cyclica's Ligand Express and Ligand Design AI platforms to identify potential leads for new medicines, the two firms said.

The platform will be used to screen, identify, design, and evaluate compounds. Cerevel has at least five clinical and seven preclinical pipelines for several neurological indications under development utilizing the platform. Cyclica's AI platform will help accelerate drug discovery and in silico drug design of Cerevel's targets.

Fox Chase creates AI program for virtual drug screening
Fox Chase Cancer Center researchers have developed a new artificial intelligence (AI) program that could make virtual screening for cancer drugs more...
From DNA to precision medicine, researchers discuss breakthroughs in cancer research
From the use of novel technologies such as machine learning and CRISPR, to gaining a deeper understanding of the genetic and molecular drivers of cancer,...
Directed evolution shows promise in reducing drug discovery times
A research collaboration between scientists at the University of Leeds and AstraZeneca resulted in the development of a technique that can significantly...
Researchers make sweet music with protein design technique
What does protein design have to do with music theory? A group of researchers from Massachusetts Institute of Technology saw commonalities between the...
From lab to clinic: How AI can help
Clinical trials are an important checkpoint in moving therapies from the lab to the clinic, and artificial intelligence (AI) software can help researchers...

Copyright © 2020 scienceboard.net

Register below for our weekly Letter from the Editor to receive the latest Science news and insights.
2020 ACCP Annual Meeting
September 20-22
Bethesda, Maryland United States
Bioprocess International West
September 21-24
Eastern Standard Time Zone (EST) United States
BioProcess International
September 21-24
Eastern Standard Time Zone (EST), Massachusetts United States
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter